Published in Thorax on May 01, 1986
Why nebulise for more than five minutes? Arch Dis Child (1989) 1.56
Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream"). Thorax (1994) 1.38
The science of nebulised drug delivery. Thorax (1997) 1.28
In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review. AAPS PharmSciTech (2007) 1.07
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.90
Effect of particle size of bronchodilator aerosols on lung distribution and pulmonary function in patients with chronic asthma. Thorax (1987) 0.89
Effect of nebulised aerosol size on lung deposition in patients with mild asthma. Thorax (1987) 0.88
Changes in maximum expiratory flow-volume curve configuration after treatment with inhaled corticosteroids. Thorax (1989) 0.88
Efficacy of cromoglycate in persistently wheezing infants. Arch Dis Child (1994) 0.86
Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax (1977) 3.35
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
Aerosol salbutamol administration by IPPB: lowest effective dose. Thorax (1978) 2.05
Distribution of bronchodilatation in normal subjects: beta agonist versus atropine. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.61
The possible site of action of sodium cromoglycate assessed by exercise challenge. Clin Sci Mol Med (1974) 1.49
Localization of beta-adrenoreceptors in mammalian lung by light microscopic autoradiography. Nature (1982) 1.30
Is the flow rate used to drive a jet nebuliser clinically important? Br Med J (Clin Res Ed) (1985) 1.15
The maximal expiratory flow-volume curve: its use in the detection of ventilatory abnormalities in a population study. Am Rev Respir Dis (1976) 1.14
Response to sympathomimetic aerosols of differing particle size in subjects with chronic bronchitis. Am Rev Respir Dis (1968) 0.88
Deposition of pressurized suspension aerosols inhaled through extension devices. Am Rev Respir Dis (1981) 4.16
Deposition of pressurised aerosols in the human respiratory tract. Thorax (1981) 3.73
Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax (1977) 3.35
Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax (1984) 3.30
Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl (1982) 3.08
Sudden death in asthma. Thorax (1979) 2.72
Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71
Factors influencing the size distribution of aerosols from jet nebulisers. Thorax (1983) 2.59
How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis (1981) 2.41
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Emergency tracheostomy. Practitioner (1975) 2.18
Use of expandable metal stents in the treatment of bronchial obstruction. Thorax (1989) 2.07
Inhalation therapy in asthma. J R Soc Med (1992) 2.01
A study of a brucellosis epidemic. Ir J Med Sci (1970) 1.99
Assessment of jet nebulisers for lung aerosol therapy. Lancet (1983) 1.99
Effects of sputum on pulmonary function. Br Med J (1977) 1.94
A one-year trial of tiotropium Respimat plus usual therapy in COPD patients. Respir Med (2010) 1.92
Droplet size distributions of nebulised aerosols for inhalation therapy. Clin Phys Physiol Meas (1986) 1.87
Evaluation of jet nebulisers for use with gentamicin solution. Thorax (1985) 1.85
Factors contributing to the reversible pulmonary hypertension of patients with acute respiratory failure studies by serial observations during recovery. Circ Res (1969) 1.77
Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax (1991) 1.65
Deposition and clearance of inhaled particles. Bull Eur Physiopathol Respir (1980) 1.61
Bronchodilator delivery from Gentlehaler, a new low-velocity pressurized aerosol inhaler. Chest (1993) 1.60
Resistance to two-phase gas-liquid flow in airways. J Appl Physiol (1970) 1.56
Effect of acute magnesium administration on the frequency of ventricular arrhythmia in patients with heart failure. Circulation (1994) 1.56
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
A comparison of biopsy results using rigid and fibreoptic bronchoscopes. Br J Dis Chest (1980) 1.47
Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax (1988) 1.44
Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol (1996) 1.44
Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J (1989) 1.43
Delivery of albuterol and ipratropium bromide from two nebulizer systems in chronic stable asthma. Efficacy and pulmonary deposition. Chest (1989) 1.41
Nebulisers: uses and abuses. Arch Dis Child (1986) 1.41
Therapeutic aerosols 1--physical and practical considerations. Thorax (1983) 1.36
Selective bronchography using the fibreoptic bronchoscope. Br J Dis Chest (1982) 1.36
Simple instructions for using pressurized aerosol bronchodilators. J R Soc Med (1980) 1.36
Lung mucociliary clearance in patients wit Young's syndrome. Chest (1981) 1.35
Obstructive azoospermia: respiratory function tests, electron microscopy and the results of surgery. Br J Urol (1978) 1.35
Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol. Am Rev Respir Dis (1978) 1.33
Measurement of bronchial mucociliary clearance. Eur J Respir Dis Suppl (1983) 1.33
Assessment of the forced expiration technique, postural drainage and directed coughing in chest physiotherapy. Eur J Respir Dis (1983) 1.30
The fractional deposition of inhaled 2 and 5 mum particles in the alveolar and tracheobronchial regions of the healthy human lung. Ann Occup Hyg (1976) 1.29
Particle penetration and clearance in the human lung. Results in healthy subjects and subjects with chronic bronchitis. Arch Environ Health (1974) 1.27
Bromhexine and mucociliary clearance in chronic bronchitis. Br J Dis Chest (1974) 1.27
Therapeutic aerosols 2--Drugs available by the inhaled route. Thorax (1984) 1.23
Aerosol inhalation and depth of deposition in the human lung. The effect of airway obstruction and tidal volume inhaled. Arch Environ Health (1977) 1.19
Airways penetration of inhaled radioaerosol: an index to small airways function? Eur J Respir Dis (1981) 1.18
No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J (1993) 1.18
Pressurised aerosol deposition in the human lung with and without an "open" spacer device. Thorax (1989) 1.17
Beclomethasone dipropionate aerosol in asthma. Transfer of steroid-dependent asthmatic patients from oral prednisone to beclomethasone dipropionate aerosol. Am Rev Respir Dis (1974) 1.17
The effect of expiratory flow rate on regional lung emptying. Clin Sci (1969) 1.15
Long-term tobacco smoking and mucociliary clearance from the human lung in health and respiratory impairment. Arch Environ Health (1973) 1.15
Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions? Thorax (1981) 1.14
A technique for monitoring the inhalation of cigarette smoke in man, using krypton-81m. Int J Appl Radiat Isot (1980) 1.13
An analysis of the first 300 fibreoptic bronchoscopies at the Brompton Hospital. Br J Dis Chest (1979) 1.11
Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction. Thorax (1979) 1.10
Pulmonary function in inflammatory bowel disease. Digestion (1978) 1.08
Impaired tracheobronchial clearance in patients with mild stable asthma. Thorax (1983) 1.08
Assessment of percussion, vibratory-shaking and breathing exercises in chest physiotherapy. Eur J Respir Dis (1985) 1.08
Wastage of drug from nebulisers: a review. J R Soc Med (1987) 1.06
No demonstrable long term effects of cigarette smoking on the mucociliary mechanism of the human lung. Nature (1970) 1.05
A preliminary study of the effect of guaiphenesin on mucociliary clearance from the human lung. Thorax (1973) 1.04
Metabolic response to intravenous salbutamol therapy in acute asthma. Thorax (1977) 1.04
Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol (1988) 1.03
The retention of lung secretions during the night in normal subjects. Clin Sci Mol Med Suppl (1978) 1.03
Chest physiotherapy: a review. Eur J Respir Dis (1982) 1.02
Techniques for measuring lung mucociliary clearance. Eur J Respir Dis Suppl (1980) 1.02
The effect of oral aminophylline on lung mucociliary clearance in man. Chest (1981) 1.02
Output characteristics of DeVilbiss No. 40 hand-held jet nebulizers. Eur Respir J (1990) 1.01
Impaired tracheobronchial clearance in bronchiectasis. Thorax (1987) 0.99
Aerosolised pentamidine. Lancet (1989) 0.99